About the Authors

Mark R. Schleiss

schleiss@umn.edu

Affiliation Division of Pediatric Infectious Diseases and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America

Sallie R. Permar

Affiliation Department of Pediatrics, Weill Cornell Medical Center, New York, New York, United States of America

Stanley A. Plotkin

Affiliations Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Vaxconsult, Doylestown, Pennsylvania, United States of America

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests. M.R.S. declares that he serves as a consultant for Moderna Vaccines and Evaxion Vaccines and serves as the site PI (University of Minnesota) for the Moderna mRNA-1647 P301 and P104 vaccine studies. M.R.S. is also a consultant for the Minnesota Department of Health, St. Paul, Minnesota. S.R.P. declares that she serves as a consultant for Merck, Moderna, Pfizer, Dynavax, Kamada, and has led sponsored research programs with Moderna, Pfizer, and Dynavax. S.A.P. has declared that no competing interests exist.